IBM and Baheal Team up to Bring Watson for Oncology to China

IBM announced that Baheal Pharmaceutical Group is extending the reach of Watson for Oncology to clinicians across China through a new multi-year strategic alliance. As the primary channel partner for Watson for Oncology in China, Baheal will serve a key role in not only accelerating cancer patients’ access to cognitive technology, but over time, may also partner to bring Watson for Genomics and other future Watson Health innovation to China.

China Released 2016 Annual Report of Drug Inspection

China’s top food and drug authority conducted overseas inspections in 19 countries for imported pharmaceuticals last year. Officials found that some companies failed to meet Chinese drug standards. The China Food and Drug Administration’s 2016 report released in Beijing on Wednesday covers its domestic and overseas drug inspections.

China inspected imported drugs from 19 countries last year, mostly in Europe and North America.
Of the 15 varieties of drugs inspected, three of them failed to pass, a higher rate than in previous years. Eight varieties withdrew their import registration certificates or had their applications returned during the inspections.

The report can be downloaded from Brückenkopf GmbH website: DOWNLOAD